Education
About Us
Working with TipRanks
Follow Us
Mettler-Toledo International (MTD)
NYSE:MTD
Top Page
Mettler-Toledo
(NYSE:MTD)
62Neutral
Positive Factors
New product innovation
MTD's Lab unit grew 5% organically, driven by new product innovation and strength in process analytics.
Profitability
Adj. EPS in the third quarter was 2% above Street expectations, indicating better-than-expected profitability.
Revenue performance
Revenues of $884M were above expectations, with certain segments like Product ID and Services showing growth.
Negative Factors
China market concerns
China's economic concerns are causing customers to delay purchases, with little upside expected from stimulus efforts.
Tariff impacts
MTD lowered its 2025 EPS outlook due to tariff impacts and reduced expectations for core growth.
Valuation concerns
The analyst's underperform rating is based on valuation concerns, with shares trading at a significant premium to the S&P.
Mettler-Toledo (MTD) vs. S&P 500 (SPY)
Market Cap
$24.46B
Dividend YieldN/A
Average Volume (3M)251.07K
Price to Earnings (P/E)27.9
Beta (1Y)1.11
Revenue Growth1.18%
EPS Growth12.34%
CountryUS
Employees16,000
SectorHealthcare
Sector Strength39
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)8.19
Shares Outstanding20,782,785
10 Day Avg. Volume224,398
30 Day Avg. Volume251,072
Financial Highlights & Ratios
PEG Ratio-24.54
Price to Book (P/B)6.97
Price to Sales (P/S)0.00
P/FCF Ratio25.85
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.61
Enterprise Value/Gross Profit10.71
Enterprise Value/Ebitda5.12
Forecast
1Y Price Target
$1,252.67Price Target Upside12.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Mettler-Toledo Business Overview & Revenue Model
Company DescriptionMettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
How the Company Makes MoneyMettler-Toledo makes money primarily through the sale of precision instruments and related services. The company's revenue streams include the sale of laboratory instruments such as balances and scales, industrial instruments for process analytics and inline measurement, and food retail solutions like checkout scales and packaging equipment. Additionally, Mettler-Toledo generates revenue from after-sales services, which include installation, calibration, and maintenance of its instruments. The company benefits from long-term service contracts and recurring maintenance agreements, which provide a steady income stream. Mettler-Toledo's ability to innovate and customize solutions for specific customer needs also plays a significant role in its financial success. Strategic partnerships and a strong global distribution network further enhance the company's market reach and revenue generation capabilities.
Mettler-Toledo Financial Statement Overview
Summary
Mettler-Toledo demonstrates strong profitability and operational efficiency with high margins, but faces challenges with negative revenue growth and historical negative equity. The robust cash flow metrics help mitigate financial risks, supporting a favorable financial outlook despite some areas of concern.Income Statement
Mettler-Toledo's TTM (Trailing-Twelve-Months) gross profit margin is 59.66%, indicating strong profitability. The net profit margin is 22.17%, reflecting efficient cost management. However, the revenue growth rate is negative at -1.09%, indicating a decline in sales compared to the previous annual report. The EBIT margin is a robust 30.54%, and the EBITDA margin stands at 31.45%, both suggesting solid operational efficiency. Despite the negative revenue growth, margins remain strong, supporting a high income statement score.75
Positive
Balance Sheet
The company's debt-to-equity ratio cannot be calculated due to negative equity in previous periods, posing a risk factor. However, the return on equity (ROE) for the TTM is not computable due to the same issue. The equity ratio for TTM is 100%, indicating full asset financing by equity. The company's high debt levels and negative equity in prior years suggest financial instability, warranting a moderate score.55
Neutral
Cash Flow
The TTM free cash flow to net income ratio is 1.02, and the operating cash flow to net income ratio is 1.15, demonstrating strong cash-generating efficiency relative to net income. The free cash flow growth rate compared to the previous annual report is 0.53%, showing stable cash flow despite revenue contraction. Overall, the cash flow position is robust, leading to a high score.80
Positive
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 3.83B | 3.87B | 3.79B | 3.92B | 3.72B | 3.09B |
| Gross Profit | |||||
| 2.29B | 2.33B | 2.24B | 2.31B | 2.17B | 1.80B |
| EBIT | |||||
| 1.17B | 1.13B | 1.15B | 1.14B | 997.84M | 797.88M |
| EBITDA | |||||
| 1.20B | 1.22B | 1.17B | 1.24B | 1.10B | 885.96M |
| Net Income Common Stockholders | |||||
| 849.22M | 863.14M | 788.78M | 872.50M | 768.99M | 602.74M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 70.19M | 59.36M | 69.81M | 95.97M | 98.56M | 94.25M |
| Total Assets | |||||
| 3.28B | 3.24B | 3.36B | 3.49B | 3.33B | 2.81B |
| Total Debt | |||||
| 2.09B | 2.01B | 2.08B | 2.01B | 1.68B | 1.33B |
| Net Debt | |||||
| 2.02B | 1.95B | 2.01B | 1.92B | 1.58B | 1.24B |
| Total Liabilities | |||||
| 3.44B | 3.37B | 3.51B | 3.47B | 3.16B | 2.53B |
| Stockholders Equity | |||||
| -158.72M | -126.89M | -149.94M | 24.79M | 171.42M | 282.68M |
| Cash Flow | Free Cash Flow | ||||
| 869.05M | 864.45M | 860.55M | 737.83M | 801.25M | 632.21M |
| Operating Cash Flow | |||||
| 972.81M | 968.35M | 965.87M | 859.07M | 908.83M | 724.70M |
| Investing Cash Flow | |||||
| -117.43M | -119.46M | -131.69M | -139.40M | -314.11M | -100.36M |
| Financing Cash Flow | |||||
| -861.04M | -855.98M | -859.59M | -716.04M | -590.55M | -743.91M |
Mettler-Toledo Technical Analysis
Negative
1117.81
Price Trends
1127.20
Negative
1207.87
Negative
1285.86
Negative
Market Momentum
7.39
Negative
52.45
Neutral
79.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Negative. The current price of 1117.81 is above the 20-day moving average (MA) of 1071.14, below the 50-day MA of 1127.20, and below the 200-day MA of 1285.86, indicating a neutral trend. The MACD of 7.39 indicates Negative momentum. The RSI at 52.45 is Neutral, neither overbought nor oversold. The STOCH value of 79.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTD.
Mettler-Toledo Risk Analysis
Mettler-Toledo disclosed 31 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Mettler-Toledo Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $40.95B | 47.07 | 59.33% | ― | 5.56% | 4.66% | |
73 Outperform | $21.36B | 31.32 | 40.82% | ― | 2.57% | 8.31% | |
72 Outperform | $32.91B | 26.53 | 20.61% | 0.84% | -3.00% | 3.67% | |
69 Neutral | $163.30B | 25.39 | 13.73% | 0.37% | 0.96% | 9.19% | |
64 Neutral | $140.71B | 38.12 | 7.22% | 0.57% | -9.19% | -12.75% | |
62 Neutral | $24.46B | 27.88 | -680.23% | ― | 1.18% | 12.34% | |
52 Neutral | $5.14B | 3.39 | -43.55% | 2.83% | 16.49% | -0.19% |
* Healthcare Sector Average
Performance Comparison
MTD
Mettler-Toledo
1,117.81
-412.74
-26.97%
A
Agilent
111.52
-41.65
-27.19%
DHR
Danaher
187.82
-75.77
-28.75%
IDXX
Idexx Laboratories
509.42
-31.52
-5.83%
TMO
Thermo Fisher
406.05
-189.37
-31.80%
WAT
Waters
345.38
-15.13
-4.20%
Mettler-Toledo Earnings Call Summary
Earnings Call Date:May 01, 2025
(Q1-2025)
| % Change Since: 5.80%|
Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment Negative
The earnings call highlighted growth in specific segments such as process analytics and product inspection, along with an increase in service sales and strong cash flow. However, significant challenges were noted, including overall sales decline, flat performance in China, and the impact of global tariffs on margins and EPS. The core industrial and food retail segments also faced declines.Q1-2025 Updates
Positive Updates
Positive Growth in Process Analytics
Strong growth in process analytics, driven by favorable biopharma market trends and innovations such as digital sensors with intelligent sensor management.
Product Inspection Business Growth
The product inspection segment showed significant growth, with an 8% increase, due to successful growth initiatives and new product innovations.
Service Sales Increase
Service sales increased by 6% in local currency in the first quarter, highlighting the strength of growth initiatives in this area.
Strong Cash Flow Position
Adjusted free cash flow amounted to $180 million in the quarter, representing a 1% increase on a per share basis.
Negative Updates
Overall Sales Decline
Sales in the quarter were $884 million, representing a decrease of 3% in local currency and a 5% decline on a U.S. dollar reported basis.
Challenges in China Market
Sales in China were flat during the quarter, with a forecast for the full year indicating a slight decline due to economic uncertainty.
Impact of Global Tariffs
Global trade disputes and tariffs are expected to cost approximately $115 million annually, with significant impact on operating margins.
Decline in Adjusted EPS
Adjusted EPS for the quarter was $8.19, an 8% decrease over the prior year.
Core Industrial Sales Decline
Core industrial sales were down 6%, reflecting mixed industry conditions across most end markets.
Food Retail Segment Decline
Food retail sales declined by 12% in the quarter, highlighting challenges in this segment.
Company Guidance
During the call, Mettler-Toledo provided guidance for the second quarter and full year 2025, forecasting local currency sales growth of 0% to 1% for Q2 and 1% to 2% for the entire year. The operating margin is expected to decrease by 170 basis points in Q2 and by 130 basis points for the full year, primarily due to the net impact of tariffs. Adjusted EPS is projected to range from $9.45 to $9.70 for Q2 and $41.25 to $42 for the year, reflecting a 0% to 2% growth, or 4% to 6% excluding shipping delays. The guidance assumes continued U.S. import tariffs and potential new tariffs, with expected mitigation actions to offset costs. Overall, the company anticipates a gross headwind of approximately 7% from higher tariffs, offset by various measures resulting in a net headwind to EPS growth of about 2%.Mettler-Toledo Corporate Events
Executive/Board ChangesBusiness Operations and Strategy
Mettler-Toledo Approves 2025 Executive Incentive Awards
Neutral
May 12, 2025
On May 8, 2025, Mettler-Toledo‘s Compensation Committee approved the 2025 long-term incentive awards for its executive officers, implementing a bifurcated grant structure to enhance retention and motivation. The awards, divided into performance share units, non-qualified stock options, and restricted stock units, reflect a strategic adjustment to the company’s compensation program, with the CEO’s target LTI value increasing by 5% and other executives by 10% compared to 2024.
The most recent analyst rating on (MTD) stock is a Buy with a $1450.00 price target. To see the full list of analyst forecasts on Mettler-Toledo stock, see the MTD Stock Forecast page.
Spark’s Take on MTD Stock
According to Spark, TipRanks’ AI Analyst, MTD is a Neutral.
Mettler-Toledo’s stock score is driven by strong profitability and cash flow, tempered by negative revenue growth and a challenging balance sheet. Technical indicators suggest a downtrend, while high valuation reflects cautious optimism. The earnings call highlighted specific growth areas but acknowledged broader market challenges, leading to a moderate investment outlook with potential risks.
To see Spark’s full report on MTD stock, click here.
Executive/Board ChangesShareholder Meetings
Mettler-Toledo Stockholders Approve Key Decisions at Annual Meeting
Positive
May 6, 2025
The annual meeting of Mettler-Toledo International Inc. stockholders took place on May 1, 2025, with a quorum present. Key outcomes included the election of eight directors for one-year terms and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm. Additionally, an advisory vote approved the executive compensation package, reflecting shareholder support for the company’s leadership and strategic direction.
Spark’s Take on MTD Stock
According to Spark, TipRanks’ AI Analyst, MTD is a Neutral.
Mettler-Toledo’s overall score is driven by strong profitability and cash flow, tempered by negative revenue growth and a challenging balance sheet. Technical indicators suggest a downtrend, while valuation is high, reflecting optimism but with caution. The earnings call highlighted specific growth areas but acknowledged broader market challenges. These factors collectively suggest a moderate investment outlook with potential risks.
To see Spark’s full report on MTD stock, click here.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.